findmyKOL
Clinical trialNCT06732388Not, yet, recruitingPhase 2Interventional

Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus

SponsorNational Cancer Institute (NCI)Enrollment64Barrett EsophagusClinical Stage I Esophageal Adenocarcinoma AJCC v8Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8Esophageal Adenocarcinoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Kansas Cancer Center

    Kansas City, Kansas, United States

    Ajay Bansal
  • University of Michigan Rogel Cancer Center

    Ann Arbor, Michigan, United States

    David Wang
  • Washington University School of Medicine

    St Louis, Missouri, United States

    Paul E. Wise
  • Unc Lineberger Comprehensive Cancer Center

    Chapel Hill, North Carolina, United States

    Nicholas J. Shaheen
  • Case Western Reserve University

    Cleveland, Ohio, United States

    Amitabh Chak
  • Baylor University Medical Center

    Dallas, Texas, United States

    Vani Konda

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
6 Oct 2026
Primary completion
1 Feb 2030
Completion
1 Feb 2030
Last update posted
13 May 2026
Registered enrollment
64
Registry id
NCT06732388

Cross-registrations

Other registry (CTRP (Clinical Trial Reporting ProgramNCI-2024-10070

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.